BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20498028)

  • 21. Identifying homozygous sickle cell disease when neonatal screening is not available: a clinic-based observational study.
    Hambleton IR; Wierenga KJ
    J Med Screen; 2004; 11(4):175-9. PubMed ID: 15563773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal screening for sickle cell anemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)].
    Galactéros F
    Pathol Biol (Paris); 1999 Jan; 47(1):13-8. PubMed ID: 10081774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sickle cell disease in heel injection screening. I].
    Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H
    Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863
    [No Abstract]   [Full Text] [Related]  

  • 24. Neonatal haemoglobinopathy screening in Burkina Faso.
    Kafando E; Nacoulma E; Ouattara Y; Ayéroué J; Cotton F; Sawadogo M; Gulbis B
    J Clin Pathol; 2009 Jan; 62(1):39-41. PubMed ID: 19103858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
    [No Abstract]   [Full Text] [Related]  

  • 26. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children.
    de Montalembert M; Ferster A; Colombatti R; Rees DC; Gulbis B;
    Am J Hematol; 2011 Jan; 86(1):72-5. PubMed ID: 20981677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
    Brunod M
    Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neonatal screening for sickle cell disease in the Consorci Sanitari de Mataro. Rationale and first results].
    Cabot Dalmau A; Casado Toda M; Barberán Pérez J; Roqueta Sureda M; Martorell Aymerich Q; Bosch Llobet A; Rovira Fernández JM
    An Esp Pediatr; 1998 Aug; 49(2):157-60. PubMed ID: 9773551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL
    J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
    Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
    Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for sickle cell disease in newborns.
    Lin KW
    Am Fam Physician; 2009 Mar; 79(6):507-8. PubMed ID: 19323364
    [No Abstract]   [Full Text] [Related]  

  • 35. [Generalized neonatal screening based on laboratory tests].
    Ardaillou R; Le Gall JY
    Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for sickle cell disease in newborns: recommendation statement.
    US Preventive Services Task Force
    Am Fam Physician; 2008 May; 77(9):1300-2. PubMed ID: 18540496
    [No Abstract]   [Full Text] [Related]  

  • 37. Newborn screening for sickle cell disease: effect on mortality.
    Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
    Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a nation-wide automated auditory brainstem response hearing screening programme in neonatal intensive care units.
    van Straaten HL; Hille ET; Kok JH; Verkerk PH;
    Acta Paediatr; 2003; 92(3):332-8. PubMed ID: 12725549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvements to the newborn bloodspot screening service are required to meet national standards.
    Bello S; Ferguson C; Wallis R
    J Med Screen; 2010; 17(3):114-20. PubMed ID: 20956720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted screening failures in neonates with sickle cell disease in metropolitan France from 2005 to 2017: Number of cases, failure circumstances and health at diagnosis.
    Remion J; Pluchart C
    Arch Pediatr; 2019 Nov; 26(8):451-452. PubMed ID: 31685410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.